Extended-interval aminoglycoside therapy for adult patients with febrile neutropenia: a systematic review.

Although the efficacy and toxicity of extended-interval (once-daily) aminoglycoside regimens is well established for immunocompetent patients, there is clinical concern about using this regimen for patients with neutropenia.